Clinical evaluation of allogeneic mesenchymal stem cells for Alzheimer's disease Human/Human trials: Inflammation
Abstract Background Therapeutic interventions that can broadly target the complex multiple pathological features of Alzheimer’s disease (AD) would be highly desirable approaches for treating these disorders. Mesenchymal stem cells (MSCs) have pleiotropic mechanisms of action that make them highly at...
Saved in:
Published in | Alzheimer's & dementia Vol. 16; no. S9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.12.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!